NCT06754124

Brief Summary

This study was planned to examine the effects of Pilates training in patients with drug-resistant epilepsy. It was planned to include 40 epilepsy patients in the study. The control group was planned to continue routine drug treatment for 8 weeks. The Pilates group was planned to receive Pilates training 3 days a week for 8 weeks in addition to routine drug treatment. It was aimed to examine the effects of Pilates training performed 3 times a week for 8 weeks on seizure frequency, core stability, balance, functional exercise capacity, cognitive functions, dual task, fatigue, kinesiophobia, sleep quality, depression and quality of life in patients with drug-resistant epilepsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2024

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

December 4, 2024

Completed
27 days until next milestone

First Posted

Study publicly available on registry

December 31, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2025

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

July 22, 2025

Status Verified

July 1, 2025

Enrollment Period

7 months

First QC Date

December 4, 2024

Last Update Submit

July 20, 2025

Conditions

Keywords

EpilepsyCognitive DysfunctionSeizuresQuality of LifeSleepDepression

Outcome Measures

Primary Outcomes (13)

  • Evaluation of Physical Activity Level

    Physical activity level will be assessed with the long form of the International Physical Activity Questionnaire (IPAQ).

    8 week

  • Evaluation of Seizure Frequency

    Seizure frequency will be calculated based on the patient's seizure diary for the 2 months prior to the assessment. Patients without a seizure diary will be given a seizure diary and asked to record their seizures for 2 months.

    8 week

  • Evaluation of the Strength of "Core" Muscles

    Core muscle strength will be assessed with sit-ups and modified push-ups. The number of times individuals can perform each test for 30 seconds will be recorded. Each measurement will be made twice and the best measurement will be used in statistical analysis.

    8 week

  • Evaluation of the Endurance of "Core" Muscles

    Static endurance of the core muscles will be assessed using the McGill protocol using the lateral bridge test, the Modified Biering-Sorensen trunk extension test, the trunk flexor endurance test, and the prone bridge test. The time that individuals can maintain the test position will be recorded in seconds using a stopwatch. Each measurement will be made twice and the best measurement will be used in the statistical analysis. The test will be terminated when individuals break the test position or say that they cannot continue the test.

    8 week

  • Evaluation of Balance

    Balance will be assessed separately with static and dynamic balance tests. The Balance Error Scoring System test will be used to assess static balance, and the Four-Step Square Test will be used to assess dynamic balance.

    8 week

  • Evaluation of Functional Exercise Capacity

    Functional exercise capacity will be assessed with the 6-Minute Walk Test (6-MWT) in accordance with the American Thoracic Society criteria.

    8 week

  • Evaluation of Cognitive Function

    Cognitive function will be assessed with the Standardized Mini Mental Test and the Neuropsychological Test Battery for Cognitive Potentials.

    8 week

  • Evaluation of Dual Task

    Dual task will be evaluated by adding a second task to the Timed Up and Go Test. For the motor task, individuals will be asked to carry an empty tray. For the cognitive task, they will be asked to count backwards from 100 by 7s (mental tracking) and to count words starting with the letter A (verbal fluency). The time will be recorded with a stopwatch. The test will be done twice, one as a trial, and the final measurement will be used in statistical analysis.

    8 week

  • Evaluation of Fatigue

    Fatigue will be assessed using the Fatigue Severity Scale.

    8 week

  • Evaluation of Kinesiophobia

    Kinesiophobia will be assessed using the Tampa Kinesiophobia Scale.

    8 week

  • Evaluation of Sleep Quality

    Sleep quality will be assessed using the Pittsburgh Sleep Quality Index.

    8 week

  • Evaluation of Depression

    The Inventory of Neurological Disorders Depression in Epilepsy will be used to assess depression.

    8 week

  • Evaluation of Quality of Life

    The Epilepsy Quality of Life Scale will be used to determine health-related quality of life in epilepsy.

    8 week

Study Arms (13)

Pilates Group

EXPERIMENTAL

Pilates training will be given individually for approximately 1 hour, 3 days a week for 8 weeks.

Other: Pilates Group

Control Group

ACTIVE COMPARATOR

Routine medication will be continued for 8 weeks.

Other: Control Group

Evaluation of seizure frequency

NO INTERVENTION

Seizure frequency will be calculated based on the patient's diary in the 2 months prior to the assessment. Patients without a seizure diary will be given one and asked to record their seizures for 2 months.

Evaluation of core stability

NO INTERVENTION

"Core" stability was evaluated with two important dimensions, "core" strength and endurance tests.

Evaluation of balance

NO INTERVENTION

Balance will be assessed separately with static and dynamic balance tests. The Balance Error Scoring System test will be used to assess static balance, and the Four-Step Square Test will be used to assess dynamic balance.

Evaluation of Functional Exercise Capacity

NO INTERVENTION

Functional exercise capacity was evaluated using the 6 Minute Walking Test (6-MWT).

Evaluation of cognitive function

NO INTERVENTION

Cognitive function will be assessed with the Standardized Mini Mental State Examination and the Neuropsychological Test Battery for Cognitive Potentials.

Evaluation of dual task

NO INTERVENTION

Dual task will be evaluated by adding a second task to the Timed Up and Go Test (TUG).

Evaluation of fatigue

NO INTERVENTION

Fatigue will be assessed using the Fatigue Severity Scale (FSS).

Evaluation of kinesiophobia

NO INTERVENTION

Kinesiophobia will be assessed with the Tampa Kinesiophobia Scale (TKS).

Evaluation of sleep quality

NO INTERVENTION

Sleep quality will be assessed by the Pittsburgh Sleep Quality Index (PSQI).

Evaluation of depression

NO INTERVENTION

The Inventory of Neurological Disorders Depression in Epilepsy will be used to assess depression.

Evaluation of quality of life

NO INTERVENTION

Quality of Life In Epilepsy (QOLIE-31) will be used to determine health-related quality of life in epilepsy.

Interventions

Pilates training will be given individually for approximately 1 hour, 3 days a week for 8 weeks. Before starting the exercise training, all participants will be taught the basic elements of Pilates in 1 session. Pilates training will begin with standing exercises for warming up and centering in the supine position. Training will continue with upper and lower extremity movements. The intensity of the exercises will be increased by using different positions and elastic bands. Stretching exercises and posture exercises will be used during the cool-down period. All exercises will start with 10 repetitions and will be increased to 20 later. Each movement will be shown by the physiotherapist first so that the patients can do the movements correctly. The movements that the patients cannot do will be modified appropriately and applied.

Pilates Group

No exercise will be allowed for 8 weeks and routine medication will continue.

Control Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being between the ages of 18-65
  • Being diagnosed with idiopathic refractory epilepsy by a specialist neurologist
  • Not having had status epilepticus for 1 year before the study
  • Being able to walk independently
  • Not having participated in a regular exercise program
  • Having a Standardized Mini Mental Test score greater than 24
  • Antiepileptic drug doses being stable during the study

You may not qualify if:

  • History of any diagnosed neurological or neuropsychiatric disease other than epilepsy
  • Presence of any cardiovascular, pulmonary, orthopedic or other medical conditions that would limit participation in the study
  • Pregnancy and breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Recep Tayyip Erdogan University Vocational School of Physical Therapy and Rehabilitation

Rize, Güneysu, 53350, Turkey (Türkiye)

Location

MeSH Terms

Conditions

EpilepsyCognitive DysfunctionSeizuresDepression

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCognition DisordersNeurocognitive DisordersMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Derya CAGLAR, PhD candidate

    Recep Tayyip Erdogan University Vocational School of Physical Therapy and Rehabilitation

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Asistant

Study Record Dates

First Submitted

December 4, 2024

First Posted

December 31, 2024

Study Start

November 15, 2024

Primary Completion

June 20, 2025

Study Completion

June 30, 2025

Last Updated

July 22, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations